AbbVie Submits BLA To FDA For Telisotuzumab Vedotin In Previously Treated Non-Small Cell Lung Cancer
AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated ...
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with long COVID Key milestone reached ...
Daily42m
USFDA issues three observations for Lupin Pithampur facility
Mumbai: Lupin has announced that the United States Food and Drug Administration (USFDA) has issued three observations each on ...
BioVie Inc. Announces Proposed Public Offering
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative ...
Daily23m
USFDA approves Bristol Myers Squibb Cobenfy for Schizophrenia treatment in adults
Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY ...
An advertising watchdog explains what’s at stake with Google’s latest DOJ case
Arielle Garcia of Check My Ads on how the trial is poised not only to disrupt the digital ad landscape but also to affect ...